Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Peter Marijnen
Introduction
Peter Marijnen is a notable inventor based in Herent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the molecular characterization of chromosome translocations associated with malignancies. With a total of 2 patents, his work has implications for understanding cancer mechanisms and developing diagnostic methods.
Latest Patents
Marijnen's latest patents focus on the molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis. These patents detail methods for determining whether a tissue sample contains cells with the chromosome 11:18 translocation, which is associated with malignancies such as mucosa-associated lymphoid tissue (MALT) lymphomas. His inventions provide insights into a novel mechanism of transformation of primary cells, involving the expression of a fusion proteinaceous molecule that includes apoptosis inhibitor 2 (API2) fused to other proteinaceous molecules. Additionally, he has introduced a novel nucleic acid sequence and a proteinaceous molecule termed 'MALT-lymphoma associated Translocation (MLT) protein.'
Career Highlights
Peter Marijnen is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of cancer biology and the development of potential therapeutic strategies.
Collaborations
Marijnen collaborates with esteemed colleagues such as Judith Dierlamm and Mathijs Baens, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Peter Marijnen's contributions to biotechnology and cancer research through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in understanding and diagnosing malignancies.